CLINICAL_TRIALS
trial_result
· 2023-03-24
Clinical Trial Update: A Study of Clevidipine Butyrate Injectable Emulsion in the Treatment of Hypertensive Emergency and Sub-emergency [Phase 3]
Summary
Phase 3 trial evaluating clevidipine butyrate injectable emulsion for hypertensive emergency; current status unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | Conditions: Hypertensive Emergency | Phase 3 | Status: UNKNOWN